Irene A. Eiseman
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 7
- HER2/EGFR in Cancer Research 7
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Pharmacogenetics and Drug Metabolism 1
- Co-authors
- Peter F. Lenehan (8 shared papers)Lee F. Allen (2 shared papers)William L. Elliott (2 shared papers)Kenneth J. Tack (4 shared papers)Stephen C. Olson (6 shared papers)Dan J. Fry (1 shared paper)Ghodrat A. Siami (1 shared paper)Nicholas V. Christou (1 shared paper)
- Journals
- Clinical Cancer Research (5 papers)Antimicrobial Agents and Chemotherapy (2 papers)Seminars in Oncology (2 papers)Drugs (2 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- United StatesCanadaSouth Africa
In The Last Decade
Irene A. Eiseman
16 papers receiving 544 citations
Peers
Comparison fields: 5 of 48
- Oncology 224
- Pulmonary and Respiratory Medicine 163
- Applied Microbiology and Biotechnology 12
- Molecular Medicine 20
- Pharmacology 28
Countries citing papers authored by Irene A. Eiseman
This map shows the geographic impact of Irene A. Eiseman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene A. Eiseman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene A. Eiseman more than expected).
Fields of papers citing papers by Irene A. Eiseman
This network shows the impact of papers produced by Irene A. Eiseman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene A. Eiseman. The network helps show where Irene A. Eiseman may publish in the future.
Co-authors
The 25 scholars most cited alongside Irene A. Eiseman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 100 | |
| 2 | 2002 | 89 | |
| 3 | 2005 | 77 | |
| 4 | 2004 | 73 | |
| 5 | 2001 | 64 | |
| 6 | 2002 | 57 | |
| 7 | 2006 | 27 | |
| 8 | 2006 | 26 | |
| 9 | 2007 | 25 | |
| 10 | 1995 | 18 | |
| 11 | 2006 | 15 | |
| 12 | 2001 | 9 | |
| 13 | 2004 | 9 | |
| 14 | 1983 | 5 | |
| 15 | 1986 | 1 | |
| 16 | 1999 | 1 |
About Irene A. Eiseman
Irene A. Eiseman is a scholar working on Oncology, Pharmacology, Infectious Diseases, Molecular Medicine and Pharmacology, having authored 16 papers that have together received 596 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (7 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Lung Cancer Treatments and Mutations (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Analytical Methods in Pharmaceuticals (1 paper), Streptococcal Infections and Treatments (1 paper), Pharmacogenetics and Drug Metabolism (1 paper) and Infective Endocarditis Diagnosis and Management (1 paper). The work is most often cited by research in Oncology (224 citations), Pulmonary and Respiratory Medicine (163 citations), Applied Microbiology and Biotechnology (12 citations), Molecular Medicine (20 citations) and Pharmacology (28 citations). Irene A. Eiseman has collaborated with scholars based in United States, Canada and South Africa. Frequent co-authors include Peter F. Lenehan, Lee F. Allen, William L. Elliott, Kenneth J. Tack, Stephen C. Olson, Dan J. Fry, Ghodrat A. Siami, Nicholas V. Christou, Alberto Chiappori and David W. Fry. Their work appears in journals such as Clinical Cancer Research, Antimicrobial Agents and Chemotherapy, Seminars in Oncology, Drugs and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.